Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2005
08/25/2005DE102004007076A1 New imidazolopyrimidine derivatives useful for controlling unwanted microorganisms, e.g. phytopathogenic fungi
08/25/2005DE102004006143A1 Neue Naphthalinderivate und diese Verbindungen enthaltende Färbemittel für Keratinfasern New naphthalene derivatives and compositions containing these compounds colorant for keratin fibers
08/25/2005CA2556404A1 Nitrogenous fused heteroaromatic ring derivative
08/25/2005CA2555884A1 Amino-substituted tricyclic derivatives and methods of use
08/25/2005CA2555287A1 Heterocyclic gaba-a subtype selective receptor modulators
08/25/2005CA2553889A1 7h-pyrrolopyrimidine derivatives
08/25/2005CA2553630A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
08/25/2005CA2549954A1 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics
08/24/2005EP1565473A1 N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors
08/24/2005EP1565472A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
08/24/2005EP1565471A1 Quinolinyl-pyrrolopyrazoles
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659931A 场致发光器件 Electroluminescent devices
08/24/2005CN1659165A Quinolinone derivatives
08/24/2005CN1659161A Piperidine derivatives having CCR3 antagonism
08/24/2005CN1659156A Novel guanidinobenzamides
08/24/2005CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
08/24/2005CN1658866A Tri-substituted heteroaryls and methods of making and using the same
08/24/2005CN1657523A Cyclic compounds
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933387 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
08/23/2005US6933386 Process for preparing certain pyrrolotriazine compounds
08/23/2005CA2137668C Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
08/18/2005WO2005076383A2 Phthalocyanine derivatives, their use as homeotropically aligned layer in electronic devices and method for the manufacturing thereof
08/18/2005WO2005075482A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
08/18/2005WO2005075481A1 Novel naphthalene derivatives and coloring agents containing these compounds, for keratin fibers
08/18/2005WO2005075480A1 Diaza- or thiazadione derivatives with neuroprotective activity
08/18/2005WO2005075479A1 Dimeric azacyclic compounds and their use
08/18/2005WO2005075460A2 Pyrrolopyrimidine derivatives for treating proliferative diseases
08/18/2005WO2005074603A2 Aminobenzoxazoles as therapeutic agents
08/18/2005WO2005058890A3 Hydronopol derivatives as agonists on human orl1 receptors
08/18/2005WO2005056554A3 Azepinoindole derivatives as pharmaceutical agents
08/18/2005WO2005055943A3 Vinorelbine derivatives
08/18/2005WO2005047242A3 Compounds containing thiosulfate moieties
08/18/2005US20050182257 Feeding a crude narcotic alkaloid solution into the chromatographic column loaded with a stationary phase media into a high performance preparative liquid;applying at least one mobile phase to the chromatographic column; andrecovering at least one narcotic alkaloid eluate
08/18/2005US20050182083 Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/18/2005US20050182078 inhibitors of cyclin-dependent kinases 2 and 4 (CDK2 and CDK4); antiproliferative agents; cancer, endometriosis, postsurgical vascular stenosis and restenosis
08/18/2005US20050182072 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182066 Methods for the production of sildenafil base and citrate salt
08/18/2005US20050182062 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof
08/18/2005US20050182061 Phthalimide compounds useful as protein kinase inhibitors
08/18/2005US20050182059 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
08/18/2005US20050182058 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005US20050182045 Fused ring 4-oxopyrimidine derivative
08/18/2005US20050181300 Photobase generator and curable composition
08/18/2005CA2555311A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
08/18/2005CA2555309A1 Phthalocyanine derivatives, their use as homeotropically aligned layer in electronic devices and method for the manufacturing thereof
08/18/2005CA2554217A1 Diaza- or thiazadione derivatives with neuroprotective activity
08/18/2005CA2553724A1 Aminobenzoxazoles as therapeutic agents
08/18/2005CA2553243A1 Pyrrolo pyrimidine derivatives useful for treating proliferative diseases
08/17/2005EP1564826A1 Phthalocyanine derivative layer in electronic multilayer devices and method for the manufacturing thereof
08/17/2005EP1564255A1 Photobase generator and curable composition
08/17/2005EP1564213A1 Imidazole derivative, process for producing the same, and use
08/17/2005EP1562959A2 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases
08/17/2005EP1562951A2 Porphyrin derivatives
08/17/2005EP1562950A1 2-substituted triazolopyrimidines, methods and intermediate products for the production thereof, the use of the same for controlling pathogenic fungi, and agents containing said compounds
08/17/2005EP1562949A2 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
08/17/2005EP1562948A2 6-(2-halogenphenyl)-triazolopyrimidines derivatives and their use as fungicide
08/17/2005EP1562947A1 4-amino-5-phenyl-7-cyclohexyl-pyrrolo[2,3-d]pyrimidine derivatives
08/17/2005EP1562945A1 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof
08/17/2005EP1562931A2 Anti-infective biaryl compounds
08/17/2005EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562589A2 Diaminotriazoles useful as inhibitors of protein kinases
08/17/2005EP1485385B1 Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
08/17/2005EP1248651B1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
08/17/2005EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
08/17/2005CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
08/17/2005CN1656098A Fused bicyclic pyrimidine derivatives
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656075A Quinoline derivatives and their use as 5-HT6 ligands
08/17/2005CN1655781A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases
08/16/2005US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis
08/16/2005US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders
08/16/2005CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them
08/11/2005WO2005073235A2 Process for the synthesis of n- [3-(3-cyanopyrazolo [1,5a] pyrimidin-7-yl)-phenyl]-n-ethyl-acetamide
08/11/2005WO2005073221A1 HETEROCYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073196A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005072530A1 Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor
08/11/2005WO2005072361A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
08/11/2005WO2005058835A3 Methods of preparing aripiprazole crystalline forms
08/11/2005WO2005056514A3 Process for preparation of substituted amino alcohols
08/11/2005WO2005054245A3 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005047290A3 Imidazo[1,2-a] pyrazin-8-ylamines as kinase inhibitors
08/11/2005WO2005046588A3 Compounds, compositions, and methods
08/11/2005WO2005044791A3 2-halogen-6-alkyl-phenyl-substituted tetramic acid derivatives
08/11/2005WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004103276A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 573